These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16087811)

  • 41. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).
    Goodman SG; Steg PG; Eagle KA; Fox KA; López-Sendón J; Montalescot G; Budaj A; Kennelly BM; Gore JM; Allegrone J; Granger CB; Gurfinkel EP;
    Am Heart J; 2006 Mar; 151(3):654-60. PubMed ID: 16504627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.
    Porto I; Selvanayagam JB; Van Gaal WJ; Prati F; Cheng A; Channon K; Neubauer S; Banning AP
    Circulation; 2006 Aug; 114(7):662-9. PubMed ID: 16894040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
    Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incremental progress? The roles of direct stenting and routine troponin measurement after percutaneous coronary intervention.
    Ellis SG
    J Invasive Cardiol; 2002 Apr; 14(4):171-2. PubMed ID: 11923568
    [No Abstract]   [Full Text] [Related]  

  • 48. Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Wenaweser P; Ramser M; Windecker S; Lütolf I; Meier B; Seiler C; Eberli FR; Hess OM
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):485-90. PubMed ID: 17894363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute myocardial infarction treated with successful primary percutaneous coronary intervention.
    Wasilewski J; Osadnik T; Poloński L
    Kardiol Pol; 2006 Sep; 64(9):967-72; discussion 973-4. PubMed ID: 17054028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study).
    Terkelsen CJ; Nørgaard BL; Lassen JF; Poulsen SH; Gerdes JC; Sloth E; Gøtzsche LB; Rømer FK; Thuesen L; Nielsen TT; Andersen HR
    Eur Heart J; 2006 Feb; 27(3):267-75. PubMed ID: 16227311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
    Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
    J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of CK-MB following percutaneous coronary intervention.
    Katritsis DG
    Eur Heart J; 2004 Jul; 25(13):1180. PubMed ID: 15231379
    [No Abstract]   [Full Text] [Related]  

  • 56. [DANAMI-2: no basis for improved survival in primary angioplasty].
    Marckmann P
    Ugeskr Laeger; 2003 Oct; 165(42):4035-6; author reply 4036. PubMed ID: 14610840
    [No Abstract]   [Full Text] [Related]  

  • 57. Creatine kinase-MB elevation following stent implantation.
    Ioannidis JP; Karvouni E; Katritsis DG
    J Am Coll Cardiol; 2005 Jun; 45(11):1908; author reply 1908-9. PubMed ID: 15936632
    [No Abstract]   [Full Text] [Related]  

  • 58. C-reactive protein and prognosis after percutaneous coronary intervention.
    Blake GJ; Ridker PM
    Eur Heart J; 2002 Jun; 23(12):923-5. PubMed ID: 12069444
    [No Abstract]   [Full Text] [Related]  

  • 59. How long is too long?
    Webb J; Humphries K; Sutandar A
    J Invasive Cardiol; 2001 Oct; 13(10):673. PubMed ID: 11581507
    [No Abstract]   [Full Text] [Related]  

  • 60. The peri-PCI enzyme rise: Speed bump or springboard to disaster?
    Blankenship J
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):325-6. PubMed ID: 18288726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.